Page last updated: 2024-11-11

himbacine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

himbacine: muscarine receptor antagonist; RN given refers to (3S-(3alpha,3aalpha,4beta(1E,2(2R*,6S*)),4abeta,8aalpha,9aalpha))-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

himbacine : A piperidine alkaloid that is decahydronaphtho[2,3-c]furan-1(3H)-one substituted by a methyl group at position 3 and a 2-[(2R,6S)-1,6-dimethylpiperidin-2-yl]ethenyl group at position 4. It has been isolated from the bark of Australian magnolias. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6436265
CHEMBL ID277642
CHEBI ID5720
SCHEMBL ID194692
MeSH IDM0138760

Synonyms (33)

Synonym
4-[2-[1,6-dimethyl-(2r,6s)-hexahydro-2-pyridinyl]-(e)-1-ethenyl]-3-methyl-(3s,3ar,4r,4as,8ar,9as)-perhydrobenzo[f]isobenzofuran-1-one
(3s,3ar,4r,4as,8ar,9as)-3-methyl-4-[2-((r)-1-methyl-6-(s)-methyl-piperidin-2-yl)-vinyl]-decahydro-naphtho[2,3-c]furan-1-one
(3s,3ar,4r,4as,8ar,9as)-4-[(e)-2-((1s,2r,6s)-1,6-dimethyl-piperidin-2-yl)-vinyl]-3-methyl-decahydro-naphtho[2,3-c]furan-1-one
bdbm50076089
(3s,3ar,4r,4as,8ar,9as)-4-[2-((3s,5r)-1,6-dimethyl-piperidin-2-yl)-vinyl]-3-methyl-decahydro-naphtho[2,3-c]furan-1-one
4-[2-(1,6-dimethyl-piperidin-2-yl)-vinyl]-3-methyl-decahydro-naphtho[2,3-c]furan-1-one
unii-m17c7v122d
m17c7v122d ,
(1s,3as,4ar,8as,9r,9ar)-9-[(e)-2-[(2r,6s)-1,6-dimethylpiperidin-2-yl]ethenyl]-1-methyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1h-naphtho[3,2-c]furan-3-one
gtpl324
nsc-23969
naphtho(2,3-c)furan-1(3h)-one, decahydro-4-(2-(1,6-dimethyl-2-piperidinyl)ethenyl)-3-methyl-,(3s-(3-alpha,3a-alpha,4-beta(1e,2(2r*,6s*)),4a-beta,8a-alpha,9a-alpha))-
nsc 23969
(3s,3ar,4r,4as,8ar,9as)-4-[(e)-2-[(2r,6s)-1,6-dimethyl-2-piperidyl]vinyl]-3-methyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3h-benzo[f]isobenzofuran-1-one
naphtho[2,3-c]furan-1(3h)-one, 4-[(1e)-2-[(2r,6s)-1,6-dimethyl-2-piperidinyl]ethenyl]decahydro-3-methyl-(3s,3ar,4r,4as,8ar,9as)-
himbacine
6879-74-9
NCGC00163249-01
CHEMBL277642 ,
chebi:5720 ,
(3s,3ar,4r,4as,8ar,9as)-4-[(e)-2-[(2r,6s)-1,6-dimethylpiperidin-2-yl]ethenyl]-3-methyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3h-benzo[f][2]benzofuran-1-one
(+)-himbacine
himbacin
(3s,3ar,4r,4as,8ar,9as)-4-((1e)-2-((2r,6s)-1,6-dimethyl-2-piperidinyl)ethenyl)decahydro-3-methylnaphtho(2,3-c)furan-1(3h)-one
naphtho(2,3-c)furan-1(3h)-one, 4-((1e)-2-((2r,6s)-1,6-dimethyl-2-piperidinyl)ethenyl)decahydro-3-methyl-, (3s,3ar,4r,4as,8ar,9as)-
himbacine [mi]
CCG-208219
SCHEMBL194692
(3s,3ar,4r,4as,8ar,9as)-4-{(e)-2-[(2r,6s)-1,6-dimethylpiperidin-2-yl]ethenyl}-3-methyldecahydronaphtho[2,3-c]furan-1(3h)-one
SR-05000002338-2
sr-05000002338
Q5765204
DTXSID401027483

Research Excerpts

Overview

Himbacine appears to be a potent muscarinic antagonist that displays selectivity for M2 or M4 receptors, as compared to M1 or M3 receptors.

ExcerptReferenceRelevance
"Himbacine appears to be a potent muscarinic antagonist that displays selectivity for M2 or M4 receptors, as compared to M1 or M3 receptors.(ABSTRACT TRUNCATED AT 250 WORDS)"( Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
Aagaard, PJ; Gibson, VA; McKinney, M; Miller, JH, 1992
)
1.28

Bioavailability

ExcerptReferenceRelevance
" 55 was highly active in several functional assays, showed excellent oral bioavailability in rat and monkey models, and showed complete inhibition of agonist-induced ex vivo platelet aggregation in cynomolgus monkeys after oral administration."( Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents.
Agans-Fantuzzi, J; Ahn, HS; Asberom, T; Boykow, G; Bryant, M; Chackalamannil, S; Chintala, M; Clasby, M; Czarniecki, M; Doller, D; Foster, C; Greenlee, WJ; Lau, J; Tsai, H; Xia, Y, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
muscarinic antagonistA drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
piperidine alkaloid
gamma-lactoneA lactone having a five-membered lactone ring.
organic heterotricyclic compoundAn organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (13)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency12.99530.000811.382244.6684AID686978
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseElectrophorus electricus (electric eel)IC50 (µMol)22.72000.00000.94539.9400AID697831
Muscarinic acetylcholine receptor M2Homo sapiens (human)IC50 (µMol)0.01750.00001.23267.7930AID141107
Muscarinic acetylcholine receptor M2Homo sapiens (human)Ki0.02340.00000.690210.0000AID142589; AID142646; AID142739; AID142853; AID238466
Muscarinic acetylcholine receptor M4Homo sapiens (human)IC50 (µMol)0.11440.00001.15467.5858AID142555
Muscarinic acetylcholine receptor M4Homo sapiens (human)Ki0.01020.00000.79519.1201AID142001; AID142591
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)Ki0.04850.00010.579710.0000AID142606; AID142739
Muscarinic acetylcholine receptor M3Rattus norvegicus (Norway rat)Ki0.04360.00011.48339.1400AID142606; AID142739
Muscarinic acetylcholine receptor M4Rattus norvegicus (Norway rat)Ki0.04360.00010.68688.2600AID142606; AID142739
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)Ki0.04360.00010.66618.2600AID142606; AID142739
Muscarinic acetylcholine receptor M5Homo sapiens (human)IC50 (µMol)1.01600.00010.99178.0000AID142561
Muscarinic acetylcholine receptor M5Homo sapiens (human)Ki0.48980.00000.72926.9183AID142273
Muscarinic acetylcholine receptor M2Rattus norvegicus (Norway rat)Ki0.04360.00010.58908.2600AID142606; AID142739
Muscarinic acetylcholine receptor M1Homo sapiens (human)IC50 (µMol)0.54820.00001.403910.0000AID142287
Muscarinic acetylcholine receptor M1Homo sapiens (human)Ki0.08510.00000.59729.1201AID141302; AID142588; AID142606; AID238465
Muscarinic acetylcholine receptor M1Mus musculus (house mouse)Ki0.10720.00160.41173.1623AID141302
Muscarinic acetylcholine receptor M3Homo sapiens (human)IC50 (µMol)0.33360.00011.01049.9280AID142433
Muscarinic acetylcholine receptor M3Homo sapiens (human)Ki0.09710.00000.54057.7600AID141590; AID142590
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (39)

Processvia Protein(s)Taxonomy
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M2Homo sapiens (human)
regulation of heart contractionMuscarinic acetylcholine receptor M2Homo sapiens (human)
response to virusMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionMuscarinic acetylcholine receptor M2Homo sapiens (human)
regulation of smooth muscle contractionMuscarinic acetylcholine receptor M2Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M2Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M2Homo sapiens (human)
signal transductionMuscarinic acetylcholine receptor M4Homo sapiens (human)
cell surface receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
regulation of locomotionMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M4Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M4Homo sapiens (human)
gastric acid secretionMuscarinic acetylcholine receptor M5Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M5Homo sapiens (human)
dopamine transportMuscarinic acetylcholine receptor M5Homo sapiens (human)
transmission of nerve impulseMuscarinic acetylcholine receptor M5Homo sapiens (human)
regulation of phosphatidylinositol dephosphorylationMuscarinic acetylcholine receptor M5Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M5Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M5Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M5Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M5Homo sapiens (human)
positive regulation of monoatomic ion transportMuscarinic acetylcholine receptor M1Homo sapiens (human)
signal transductionMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
neuromuscular synaptic transmissionMuscarinic acetylcholine receptor M1Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M1Homo sapiens (human)
regulation of locomotionMuscarinic acetylcholine receptor M1Homo sapiens (human)
saliva secretionMuscarinic acetylcholine receptor M1Homo sapiens (human)
cognitionMuscarinic acetylcholine receptor M1Homo sapiens (human)
regulation of postsynaptic membrane potentialMuscarinic acetylcholine receptor M1Homo sapiens (human)
regulation of glial cell proliferationMuscarinic acetylcholine receptor M1Homo sapiens (human)
positive regulation of intracellular protein transportMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
postsynaptic modulation of chemical synaptic transmissionMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M1Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M1Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M1Homo sapiens (human)
calcium-mediated signalingMuscarinic acetylcholine receptor M3Homo sapiens (human)
regulation of monoatomic ion transmembrane transporter activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
signal transductionMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
synaptic transmission, cholinergicMuscarinic acetylcholine receptor M3Homo sapiens (human)
nervous system developmentMuscarinic acetylcholine receptor M3Homo sapiens (human)
positive regulation of insulin secretionMuscarinic acetylcholine receptor M3Homo sapiens (human)
protein modification processMuscarinic acetylcholine receptor M3Homo sapiens (human)
positive regulation of smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
saliva secretionMuscarinic acetylcholine receptor M3Homo sapiens (human)
acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled serotonin receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
ligand-gated ion channel signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
regulation of smooth muscle contractionMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerMuscarinic acetylcholine receptor M3Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathwayMuscarinic acetylcholine receptor M3Homo sapiens (human)
chemical synaptic transmissionMuscarinic acetylcholine receptor M3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M2Homo sapiens (human)
arrestin family protein bindingMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M2Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M4Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M4Homo sapiens (human)
phosphatidylinositol phospholipase C activityMuscarinic acetylcholine receptor M5Homo sapiens (human)
protein bindingMuscarinic acetylcholine receptor M5Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M5Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M5Homo sapiens (human)
phosphatidylinositol phospholipase C activityMuscarinic acetylcholine receptor M1Homo sapiens (human)
protein bindingMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M1Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M1Homo sapiens (human)
phosphatidylinositol phospholipase C activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
protein bindingMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled acetylcholine receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
signaling receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
acetylcholine bindingMuscarinic acetylcholine receptor M3Homo sapiens (human)
G protein-coupled serotonin receptor activityMuscarinic acetylcholine receptor M3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (18)

Processvia Protein(s)Taxonomy
plasma membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
clathrin-coated endocytic vesicle membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
asymmetric synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
symmetric synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
presynaptic membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
neuronal cell bodyMuscarinic acetylcholine receptor M2Homo sapiens (human)
axon terminusMuscarinic acetylcholine receptor M2Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
glutamatergic synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
cholinergic synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M2Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M2Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M2Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M4Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M4Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M4Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M4Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M4Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M5Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M5Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M5Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M5Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M5Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
presynaptic membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
axon terminusMuscarinic acetylcholine receptor M1Homo sapiens (human)
Schaffer collateral - CA1 synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
postsynaptic density membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
glutamatergic synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
cholinergic synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M1Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M1Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M1Homo sapiens (human)
endoplasmic reticulum membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
basal plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
basolateral plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
postsynaptic membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
synapseMuscarinic acetylcholine receptor M3Homo sapiens (human)
plasma membraneMuscarinic acetylcholine receptor M3Homo sapiens (human)
dendriteMuscarinic acetylcholine receptor M3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (50)

Assay IDTitleYearJournalArticle
AID142561Evaluated for its binding affinity at human muscarinic receptor m5 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Identification and characterization of m4 selective muscarinic antagonists.
AID697829Inhibition of horse BChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID142273Affinity for Muscarinic acetylcholine receptor M5 expressed in CHO cells by [3H]NMS displacement.2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.
AID697831Inhibition of electric eel AChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID141590Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.
AID141107Evaluated for its binding affinity at human muscarinic receptor m2 by displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Identification and characterization of m4 selective muscarinic antagonists.
AID142433Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Identification and characterization of m4 selective muscarinic antagonists.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697834Inhibition of horse BChE at 10 uM by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID141302Affinity for Muscarinic acetylcholine receptor M1 expressed in CHO cells by [3H]NMS displacement.2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.
AID141112The compound was tested in vitro for binding activity against M2 muscarinic receptor in homogenates of the brainstem of rat using [3H]quinuclidinyl benzilate (QNB) as radioligand2002Bioorganic & medicinal chemistry letters, Nov-18, Volume: 12, Issue:22
Synthesis and muscarinic M(2) subtype antagonistic activity of enantiomeric pairs of 3-demethylhimbacine (3-norhimbacine) and its C(4)-epimer.
AID238465In vitro inhibitory activity against cloned human M1 muscarinic receptor2004Bioorganic & medicinal chemistry letters, Aug-02, Volume: 14, Issue:15
Himbacine analogs as muscarinic receptor antagonists--effects of tether and heterocyclic variations.
AID142590Binding affinity against human muscarine receptor (hM3) cloned in CHO cells2002Bioorganic & medicinal chemistry letters, Aug-05, Volume: 12, Issue:15
Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.
AID142589Binding affinity against human muscarine receptor (hM2) cloned in CHO cells2002Bioorganic & medicinal chemistry letters, Aug-05, Volume: 12, Issue:15
Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.
AID142646Affinity for Muscarinic acetylcholine receptor M2 expressed in CHO cells by [3H]NMS displacement.2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.
AID142853Binding affinity towards human muscarinic M2 receptor in CHO-KI cells using [3H]- QNB as radioligand1999Bioorganic & medicinal chemistry letters, Mar-22, Volume: 9, Issue:6
Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists.
AID142591Binding affinity against human muscarine receptor (hM4) cloned in CHO cells2002Bioorganic & medicinal chemistry letters, Aug-05, Volume: 12, Issue:15
Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.
AID142001Affinity for Muscarinic acetylcholine receptor M4 expressed in CHO cells by [3H]NMS displacement.2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.
AID142588Binding affinity against human muscarine receptor (hM1) cloned in CHO cells2002Bioorganic & medicinal chemistry letters, Aug-05, Volume: 12, Issue:15
Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.
AID142287Evaluated for its binding affinity at human muscarinic receptor m1 by displacement of [3H]NMS binding using membranes in transfected chinese hamster ovarian cell1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Identification and characterization of m4 selective muscarinic antagonists.
AID142739Binding affinity against the muscarinic M1 (cortex) subtype was evaluated using [3H]pirenzepine2002Bioorganic & medicinal chemistry letters, Oct-21, Volume: 12, Issue:20
Synthesis and muscarinic M2 subtype antagonistic activity of unnatural ent-himbacine and an enantiomeric pair of (2'S,6'R)-diepihimbacine.
AID697830Inhibition of human BChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID141111The compound was tested in vitro for binding activity against M1 muscarinic receptor in homogenates of the cerebral cortex of rat using [3H]pirenzepine as radioligand2002Bioorganic & medicinal chemistry letters, Nov-18, Volume: 12, Issue:22
Synthesis and muscarinic M(2) subtype antagonistic activity of enantiomeric pairs of 3-demethylhimbacine (3-norhimbacine) and its C(4)-epimer.
AID238466In vitro inhibitory activity against cloned human M2 muscarinic receptor2004Bioorganic & medicinal chemistry letters, Aug-02, Volume: 14, Issue:15
Himbacine analogs as muscarinic receptor antagonists--effects of tether and heterocyclic variations.
AID140988Binding affinity against the muscarinic M2 (brainstem) subtype was evaluated using [3H]quinuclidinyl benzilate2002Bioorganic & medicinal chemistry letters, Oct-21, Volume: 12, Issue:20
Synthesis and muscarinic M2 subtype antagonistic activity of unnatural ent-himbacine and an enantiomeric pair of (2'S,6'R)-diepihimbacine.
AID142606Binding affinity towards human muscarinic M1 receptor in CHO-KI cells using [3H]- QNB as radioligand1999Bioorganic & medicinal chemistry letters, Mar-22, Volume: 9, Issue:6
Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists.
AID142555Evaluated for its binding affinity at human muscarinic receptor m4 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell1998Bioorganic & medicinal chemistry letters, Aug-04, Volume: 8, Issue:15
Identification and characterization of m4 selective muscarinic antagonists.
AID1345286Human M1 receptor (Acetylcholine receptors (muscarinic))1994FEBS letters, Sep-19, Volume: 352, Issue:1
A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors.
AID1345326Human M2 receptor (Acetylcholine receptors (muscarinic))1998The Journal of pharmacology and experimental therapeutics, Feb, Volume: 284, Issue:2
Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line.
AID1345343Human M3 receptor (Acetylcholine receptors (muscarinic))1991The Journal of pharmacology and experimental therapeutics, Feb, Volume: 256, Issue:2
Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
AID1345286Human M1 receptor (Acetylcholine receptors (muscarinic))1992The Journal of pharmacology and experimental therapeutics, Nov, Volume: 263, Issue:2
Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
AID1345343Human M3 receptor (Acetylcholine receptors (muscarinic))1994FEBS letters, Sep-19, Volume: 352, Issue:1
A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors.
AID1345543Human M5 receptor (Acetylcholine receptors (muscarinic))1991The Journal of pharmacology and experimental therapeutics, Feb, Volume: 256, Issue:2
Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
AID1345343Human M3 receptor (Acetylcholine receptors (muscarinic))1992The Journal of pharmacology and experimental therapeutics, Nov, Volume: 263, Issue:2
Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
AID1345543Human M5 receptor (Acetylcholine receptors (muscarinic))1992The Journal of pharmacology and experimental therapeutics, Nov, Volume: 263, Issue:2
Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
AID1345326Human M2 receptor (Acetylcholine receptors (muscarinic))1994FEBS letters, Sep-19, Volume: 352, Issue:1
A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors.
AID1345465Human M4 receptor (Acetylcholine receptors (muscarinic))1994FEBS letters, Sep-19, Volume: 352, Issue:1
A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors.
AID1345364Rat M2 receptor (Acetylcholine receptors (muscarinic))1998The Journal of pharmacology and experimental therapeutics, Feb, Volume: 284, Issue:2
Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line.
AID1345326Human M2 receptor (Acetylcholine receptors (muscarinic))1992The Journal of pharmacology and experimental therapeutics, Nov, Volume: 263, Issue:2
Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
AID1345465Human M4 receptor (Acetylcholine receptors (muscarinic))1991The Journal of pharmacology and experimental therapeutics, Feb, Volume: 256, Issue:2
Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
AID1345326Human M2 receptor (Acetylcholine receptors (muscarinic))1991The Journal of pharmacology and experimental therapeutics, Feb, Volume: 256, Issue:2
Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
AID1345543Human M5 receptor (Acetylcholine receptors (muscarinic))1994FEBS letters, Sep-19, Volume: 352, Issue:1
A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors.
AID1345286Human M1 receptor (Acetylcholine receptors (muscarinic))1991The Journal of pharmacology and experimental therapeutics, Feb, Volume: 256, Issue:2
Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
AID1345465Human M4 receptor (Acetylcholine receptors (muscarinic))1992The Journal of pharmacology and experimental therapeutics, Nov, Volume: 263, Issue:2
Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (72)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (6.94)18.7374
1990's27 (37.50)18.2507
2000's29 (40.28)29.6817
2010's6 (8.33)24.3611
2020's5 (6.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.45 (24.57)
Research Supply Index4.30 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (4.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other70 (95.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]